A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we introduce a method for performing round spermatid injection (ROSI) in mice, a technique with promising clinical applications and utility for investigating the mechanisms underlying embryonic development.
Round spermatids, characterized by their haploid genetic content, represent the precursor cells to mature spermatozoa. Through the innovative technique of round spermatid injection (ROSI), oocytes can be successfully fertilized and developed into viable fetuses. In a groundbreaking milestone achieved in 1995, the first mouse fetus was born through ROSI technology. ROSI has since emerged as a pivotal tool for unraveling the intricate mechanisms governing embryonic development and holds significant potential in various applications, including the acceleration of mouse generation and the production of genetically modified mice. In 1996, a milestone was reached when the first human fetus was born through ROSI technology. However, the clinical applications of this method have shown a fluctuating pattern of success and failure. To date, ROSI technology has not found widespread application in clinical practice, primarily due to its low birth efficiency and insufficient validation of fetal safety. This article provides a comprehensive account of the precise methods of performing ROSI in mice, aiming to shed new light on basic research and its potential clinical applications.
The final stage of spermatogenesis involves the transformation of a round spermatid into a fully developed spermatozoon, characterized by distinct head, neck, and elongated tail structures1. This transformation encompasses significant changes in cell morphology, such as the condensation of chromatin in the nucleus, replacement of histones by protamine, acrosome formation, mitochondrial sheath development, centriole migration and loss, tail structure formation, and the removal of cellular residues2.
In 1992, the first human fetus was successfully born through intracytoplasmic sperm injection (I....
B6D2F1 (C57BL/6 x DBA/2), C57BL/6, and ICR mice used in this experiment were purchased from Beijing Vital River Laboratory Animal Technologies Co. Ltd. (Beijing, China). All animal treatments adhered to the experimental procedures and standards approved by the Experimental Animal Ethics Committee of the First Hospital of Jilin University (approval number: 20200435).
1. Preparation of relevant reagents
We initiated our investigation by examining AOA's effect on embryos' developmental capability. A schematic illustration of the experimental design is shown in Figure 1A. Before the spermatozoon injection, the oocytes underwent either AOA (A-ICSI) or remained untreated (ICSI). Detailed data on embryonic development is presented in Table 1. The results revealed no significant differences in cleavage, blastocyst, or birth rates between the A-ICSI and ICSI groups (P<.......
Assisted oocyte activation
A critical prerequisite for ROSI is AOA since round spermatids alone cannot initiate oocyte activation. Currently, the most established method in mice involves the use of strontium chloride23,24, while the most advanced human application employs electrical activation13,14. The timing of oocyte activation is also of great significance. As reported in the li.......
We extend our gratitude to Wenjie Zhao for her invaluable assistance in sorting round spermatids through flow cytometry and to Fang Wang for her expertise in mouse embryo transfer. This work received partial support from the Natural Science Foundation of Jilin Province (No. YDZJ202301ZYTS461). We thank Bullet Edits Limited for the linguistic editing and proofreading of the manuscript.
....Name | Company | Catalog Number | Comments |
CaCl22H2OÂ | Sigma | C7902Â | Preparation of CZB |
Glucose | Sigma | G6152 | Preparation of CZB |
HEPES-Na (basic)Â | Sigma | H3784Â | Preparation of CZB |
Hoechst 33342 | Beyotime | C1025 | FACS |
human chorionic gonadotropin (HCG) | Ningbo Second Hormone Company | HCG | Ovulation promoting drugs |
Hyaluronidase | Sigma | H3506 | Removing granulosa cells around the oocyte |
KCl | Sigma | P5405 | Preparation of CZB |
KH2PO4Â | Sigma | P5655Â | Preparation of CZB |
KSOMaa | Caisson Labs | IVL04-100ML | Potassium simplex optimized medium supplemented with amino acids |
L-glutamine | Sigma | G8540 | Preparation of CZB |
M2 | Sigma | M7167-50ML | Operating fluid |
MgSO47H2OÂ | Sigma | M1880Â | Preparation of CZB |
Na2-EDTA2H2OÂ | Sigma | E5134Â | Preparation of CZB |
NaCl | Sigma | S5886 | Preparation of CZB |
NaHCO3 | Sigma | S5761Â | Preparation of CZB |
Na-lactate 60% syrup d = 1.32 g/L | Sigma | L7900Â | Preparation of CZB |
Na-pyruvate | Sigma | P4562 | Preparation of CZB |
Piezo drill tips (ICSI) | Eppendorf | piezoXpert | Piezoelectric membrane rupture |
pregnant mare serum gonadotropin (PMSG) | Ningbo Second Hormone Company | PMSG | Ovulation promoting drugs |
PVAÂ | Sigma | P8136 | Preparation of CZB |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved